Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma

被引:1
作者
Baues, Christian [1 ,2 ,3 ]
Goergen, Helen [3 ]
Semrau, Robert [4 ]
Nast-Kolb, Beatrix [5 ]
Assenmacher, Katja [1 ,2 ]
Celik, Eren [1 ,2 ]
Morgenthaler, Janis [1 ,2 ]
Rosenbrock, Johannes [1 ,2 ]
Trommer-Nestler, Maike [1 ,2 ]
Houbois, Christian [6 ]
Kobe, Carsten [7 ]
Kriz, Jan [8 ]
Engert, Andreas [3 ,9 ]
Marnitz, Simone [1 ,2 ,3 ]
机构
[1] Univ Hosp Cologne, Dept Radiat Oncol, Cologne, Germany
[2] Univ Hosp Cologne, Cyberknife Ctr, Cologne, Germany
[3] Univ Hosp Cologne, German Hodgkin Study Grp, Cologne, Germany
[4] Bonn Rhein Sieg, Radiat Oncol, Siegbur, Germany
[5] Marienhospital, Dept Radiooncol, Dusseldorf, Germany
[6] Univ Hosp Cologne, Dept Radiol, Cologne, Germany
[7] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[8] Univ Hosp Muenster, Dept Radiat Oncol, Munster, Germany
[9] Univ Hosp Cologne, Dept Internal Med & Hematol, Cologne, Germany
关键词
Hodgkin lymphoma; large mediastinal tumor; risk factor; volumetry; TUMOR BURDEN; PROGNOSTIC-FACTORS; OPEN-LABEL; DISEASE; TOMOGRAPHY; TRIAL; ABVD;
D O I
10.1080/10428194.2019.1623888
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The large mediastinal mass (LMM) at initial staging represents a risk factor in Hodgkin lymphoma (HL) and is measured by X-ray. Depending on location of the LMM, different results can occur regardless of the initial lymphoma volume. To assess this risk factor more accurately, we evaluated the method of volumetry in 77 patients of HD13/14 study of the German Hodgkin Study Group. Furthermore, volume calculations based on three or only one diameter, were performed to simplify volume assessment. Inter-rater reliability was good for all methods. The 3-diameter measurement produced larger volumes than volumetric assessment with an intraclass correlation coefficient (ICC) of 0.93, which could be improved to 0.95 by multiplying volumes with a correction factor of 0.86. The 1-dimensional measurement strongly overestimated the volume with an ICC of 0.7. In conclusion, the simplified volume estimation based on 3 largest diameters provides a reliable concept for the staging of HL patients.
引用
收藏
页码:3244 / 3250
页数:7
相关论文
共 21 条
[1]   Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial [J].
Behringer, Karolin ;
Goergen, Helen ;
Hitz, Felicitas ;
Zijlstra, Josee M. ;
Greil, Richard ;
Markova, Jana ;
Sasse, Stephanie ;
Fuchs, Michael ;
Topp, Max S. ;
Soekler, Martin ;
Mathas, Stephan ;
Meissner, Julia ;
Wilhelm, Martin ;
Koch, Peter ;
Lindemann, Hans-Walter ;
Schalk, Enrico ;
Semrau, Robert ;
Kriz, Jan ;
Vieler, Tom ;
Bentz, Martin ;
Lange, Elisabeth ;
Mahlberg, Rolf ;
Hassler, Andre ;
Vogelhuber, Martin ;
Hahn, Dennis ;
Mezger, Joerg ;
Krause, Stefan W. ;
Skoetz, Nicole ;
Boell, Boris ;
von Tresckow, Bastian ;
Diehl, Volker ;
Hallek, Michael ;
Borchmann, Peter ;
Stein, Harald ;
Eich, Hans ;
Engert, Andreas .
LANCET, 2015, 385 (9976) :1418-1427
[2]   PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group [J].
Borchmann, Peter ;
Goergen, Helen ;
Kobe, Carsten ;
Lohri, Andreas ;
Greil, Richard ;
Eichenauer, Dennis A. ;
Zijlstra, Josee M. ;
Markova, Jana ;
Meissner, Julia ;
Feuring-Buske, Michaela ;
Huttmann, Andreas ;
Dierlamm, Judith ;
Soekler, Martin ;
Beck, Hans-Joachim ;
Willenbacher, Wolfgang ;
Ludwig, Wolf-Dieter ;
Pabst, Thomas ;
Topp, Max S. ;
Hitz, Felicitas ;
Bentz, Martin ;
Keller, Ulrich Bernd ;
Kuhnhardt, Dagmar ;
Ostermann, Helmut ;
Schmitz, Norbert ;
Hertenstein, Bernd ;
Aulitzky, Walter ;
Maschmeyer, Georg ;
Vieler, Tom ;
Eich, Hans ;
Baues, Christian ;
Stein, Harald ;
Fuchs, Michael ;
Kuhnert, Georg ;
Diehl, Volker ;
Dietlein, Markus ;
Engert, Andreas .
LANCET, 2017, 390 (10114) :2790-2802
[3]   Assessment and significance of mediastinal bulk in Hodgkin's disease: Comparison between computed tomography and chest radiography [J].
Bradley, AJ ;
Carrington, BM ;
Lawrance, JAL ;
Ryder, WDJ ;
Radford, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2493-2498
[4]   Prognostic factors in Hodgkin lymphoma [J].
Broeckelmann, Paul J. ;
Angelopoulou, Maria K. ;
Vassilakopoulos, Theodoros P. .
SEMINARS IN HEMATOLOGY, 2016, 53 (03) :155-164
[5]   Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy [J].
Gobbi, Paolo G. ;
Bergonzi, Manuela ;
Bassi, Emilio ;
Merli, Francesco ;
Coriani, Chiara ;
Federico, Massimo .
HEMATOLOGICAL ONCOLOGY, 2013, 31 (03) :151-155
[6]   Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy [J].
Gobbi, Paolo G. ;
Bassi, Emilio ;
Bergonzi, Manuela ;
Merli, Francesco ;
Coriani, Chiara ;
Iannitto, Emilio ;
Luminari, Stefano ;
Polimeno, Giuseppe ;
Federico, Massimo .
HEMATOLOGICAL ONCOLOGY, 2012, 30 (04) :194-199
[7]   Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters [J].
Gobbi, Paolo G. ;
Bergonzi, Manuela ;
Bassi, Emilio ;
Merli, Francesco ;
Coriani, Chara ;
Stelitano, Caterina ;
Iannitto, Emilio ;
Federico, Massimo .
ONCOLOGY REPORTS, 2012, 28 (03) :815-820
[8]   Image-aided estimate of tumor burden in Hodgkin's disease:: Evidence of its primary prognostic importance [J].
Gobbi, PG ;
Ghirardelli, ML ;
Solcia, M ;
Di Giulio, G ;
Merli, F ;
Tavecchia, L ;
Bertè, R ;
Davini, O ;
Levis, A ;
Broglia, C ;
Maffè, GC ;
Ilariucci, F ;
Dore, R ;
Ascari, E .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1388-1394
[9]   Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma Is the definition on the basis of a chest radiograph in the era of CT obsolete? [J].
Kriz, J. ;
Mueller, R. -P. ;
Mueller, H. ;
Kuhnert, G. ;
Engert, A. ;
Kobe, C. ;
Haverkamp, U. ;
Eich, H. T. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (11) :1020-1024
[10]  
MAUCH P, 1978, CANCER-AM CANCER SOC, V42, P1039, DOI 10.1002/1097-0142(197809)42:3<1039::AID-CNCR2820420302>3.0.CO